Role of the NF-κB signaling pathway and κB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide

Infection and Immunity

Volumn 71, Issue 3, 2003, Pages 1442-1452

  Morris, Kristin R ^a   Lutz, Ryan D ^a   Choi, Hyung Seok ^a   Kamitani, Tetsu ^d   Chmura, Kathryn ^a   Chan, Edward D ^a,b,c,d  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; LIPOARABINOMANNAN; MANNOSE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; DNA BINDING PROTEIN; I KAPPA B; INDUCIBLE NITRIC OXIDE SYNTHASE; IRF1 PROTEIN, MOUSE; LIPOPOLYSACCHARIDE; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NOS2 PROTEIN, MOUSE; PHOSPHOPROTEIN;

ANIMAL CELL; ARTICLE; BACTERIAL CELL WALL; BINDING SITE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME INDUCTION; GENE MUTATION; HOST RESISTANCE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REPORTER GENE; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; DNA FLANKING REGION; GEL MOBILITY SHIFT ASSAY; GENETICS; PHYSIOLOGY;

MYCOBACTERIUM TUBERCULOSIS;

5' FLANKING REGION; ANIMALS; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; I-KAPPA B PROTEINS; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION;

EID: 0037332589     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.3.1442-1452.2003     Document Type: Article

References (76)

1. Adams, L. B., M. C. Dinauer, D. E. Morgenstern, and J. L Krahenbuhl. 1997. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuber. Lung Dis. 78:237-246.
2. Adams, L. B., Y. Fukutomi, and J. L. Krahenbuhl. 1993. Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence. Infect. Immun. 61:4173-4181.
3. Alepuz, P. M., A. Jovanovic, V. Reiser, and G. Ammerer. 2001. Stress-induced MAP kinase Hog1 is part of transcription activation complexes. Mol. Cell 7:767-777.
4. Alpert, D., P. Schwenger, J. Han, and J. Vilcek. 1999. Cell stress and MKK6b-mediated p38 MAP kinase activation inhibit tumor necrosis factor-induced IκB phosphorylation and NF-κB activation. J. Biol. Chem. 274: 22176-22183.
5. Baeuerle, P. A. 1998. Pro-inflammatory signaling: last pieces in the NF-κB puzzle? Curr. Biol. 8:R19-R22.
6. Baldwin, A. S. 2001. The transcription factor NF-κB and human disease. J. Clin. Investig. 107:3-6.
7. Barnes, P. F., D. Chatterjee, J. S. Abrams, S. Lu, E. Wang, M. Yamamura, P. J. Brennan, and R. L. Modlin. 1992. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. J. Immunol. 149:541-547.
8. Birkenkamp, K. U., L. M. L. Tuyt, C. Lummen, A. T. J. Wierenga, W. Kruijer, and E. Vellenga. 2000. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-κB transcriptional activity by a non-specific effect upon the ERK pathway. Br. J. Pharmacol. 131:99-107.
9. Blackwell, T. S., and J. W. Christman. 1997. The role of nuclear factor-κB in cytokine gene regulation. Am. J. Respir. Cell Mol. Biol. 17:3-9.
10. Bowie, A. G., and L. A. J. O'Neill. 2000. Vitamin C inhibits NF-κB activation by TNF via the activation of p38 mitogen-activated protein kinase. J. Immunol. 165:7180-7188.
11. Carter, A. B., and G. W. Hunninghake. 2000. A constitutive active MEK→ERK pathway negatively regulates NF-κB-dependent gene expression by modulating TATA-binding protein phosphorylation. J. Biol. Chem. 275:27858-27864.
12. Carter, A. B., K. L. Knudtson, M. M. Monick, and G. W. Hunninghake. 1999. The p38 mitogen-activated protein kinase is required for NF-κB-dependent gene expression. J. Biol. Chem. 274:30858-30863.
13. Chan, E. D., K. R. Morris, J. T. Belisle, P. Hill, L. K. Remigio, P. J. Brennan, and D. W. H. Riches. 2001. Induction of iNOS-NO by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-κB signaling pathways. Infect. Immun. 69:2001-2010.
14. mapk in a mouse macrophage cell line. Am. J. Physiol. Cell Physiol. 280:C441-C450.
15. Chan, E. D., B. W. Winston, S.-T. Uh, M. W. Wynes, D. M. Rose, and D. W. H. Riches. 1999. Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-γ and TNFα in mouse macrophages. J. Immunol. 162:415-422.
16. Chan, J., K. Tanaka, D. Carroll, J. Flynn, and B. R. Bloom. 1995. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 63:736-740.
17. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages J. Exp. Med. 175:1111-1122.
18. Chatterjee, D., and K.-H. Khoo. 1998. Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 8:113-120.
19. Chatterjee, D., K. Lowell, B. Rivoire, M. R. McNeil, and P. J. Brennan. 1992. Lipoarabinomannan of Mycobacterium tuberculosis. J. Biol. Chem. 267:6234-6239.
20. Chatterjee, D., A. D. Roberts, K. Lowell, P. J. Brennan, and I. M. Orme. 1992. Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect. Immun. 60:1249-1253.
21. Cooper, A. M., J. P. Pearl, J. V. B. Brooks, S. Ehlers, and I. M. Orme. 2000. Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect. Immun. 68:6879-6882.
22. Cota-Gomez, A., N. C. Flores, C. Cruz, A. Casullo, T. Y. Aw, H. Ichikawa, J. Schaack, R. Scheinman, and S. C. Flores. 2002. The human immunodeficiency virus-1 Tat protein activates human umbilical vein endothelial cell E-selectin expression via an NF-κB-dependent mechanism. J. Biol. Chem. 277:14390-14399.
23. Cullen, B. R., and M. H. Malim. 1992. Secreted placental alkaline phosphatase as a eukaryotic reporter gene. Methods Enzymol. 216:362-368.
24. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412.
25. Ellner, J. J., and T. M. Daniel. 1979. Immunosuppression by mycobacterial arabinomannan. Clin. Exp. Immunol. 35:250-257.
26. Fang, F. C. 1997. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Investig. 100:S43-S50.
27. 2 synthesis in human neuroblastoma cells: Involvement of p38 mitogen-activated protein kinase and nuclear factor-κB. J. Neurochem. 75:2020-2028.
28. Fiebich, B. L., S. Schleichers, R. D. Butcher, A. Craig, and K. Lieb. 2000. The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-κB. J. Immunol. 165: 5606-5611.
29. Geller, D. A., C. J. Lowenstein, R. A. Shapiro, A. K. Nussler, M. DiSilvio, S. C. Wang, D. K. Nakayama, R. L. Simmons, S. H. Snyder, and T. R. Billiar. 1993. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA 90:3491-3495.
30. Giri, D. K., R. T. Mehta, R. G. Kansal, and B. B. Aggarwal. 1998. Mycobacterium avium-intracellulare complex activates nuclear transcription factor-κB in different cell types through reactive oxygen intermediates. J. Immunol. 161:4834-4841.
31. Green, S. J., R. M. Crawford, J. T. Hockmeyer, M. S. Meltzer, and C. A. Nacy. 1990. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-γ-stimulated macrophages by induction of TNF-α. J. Immunol. 145:4290-4297.
32. Ivanov, V. N., and Z. Ronai. 2000. p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-κB activity and Fas expression. Oncogene 19:3003-3012.
33. Jagannath, C., J. K. Actor, and R. L. J. Hunter. 1998. Induction of nitric oxide in human monocytes and monocyte cell lines by Mycobacterium tuberculosis. Nitric Oxide 2:174-186.
34. Jobin, C., A. Panja, C. Hellerbrand, Y. Iimuro, J. Didonato, D. A. Brenner, and R. B. Sartor. 1998. Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor κB super-repressor in human intestinal epithelial cells. J. lmmunol. 160:410-418.
35. Jones, C. A., and J. K. Brown. 1999. p38 inhibition increases ERK1/ERK2 kinase activity and DNA synthesis in airway smooth muscle cells: evidence for cross-talk between mitogen-activated protein (MAP) kinase cascades. Am. J. Respir. Crit. Care Med. 159:A722.
36. Kamijo, R., H. Harada, T. Matsuyama, M. Bosland, J. Gerecitano, D. Shapiro, J. Le, S. I. Koh, T. Kimura, S. Green, T. W. Mak, T. Taniguchi, and J. Vilcek. 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612-1615.
37. Kan, H., Z. Xie, and M. S. Finkel. 1999. TNF-α enhances cardiac myocyte NO production through MAP kinase-mediated NF-κB activation. Am. J. Physiol. 277:H1641-H1646.
38. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621-663.
39. Karin, M., and A. Lin. 2002. NF-κB at the crossroads of life and death. Nat. Immunol. 3:221-227.
40. Kim, H. C., J. H. Kim, J. W. Park, G. Y. Suh, M. P. Chung, O. J. Kwon, C. H. Rhee, and Y. C. Han. 1997. Difference of nitric oxide production in peripheral blood mononuclear cells and airway epithelial cells between healthy volunteers and patients with tuberculosis. Tuberc. Respir. Dis. 44(Suppl. 2):72-75.
41. Kushner, D. B., and R. P. Ricciardi. 1999. Reduced phosphorylation of p50 is responsible for diminished NF-κB binding to the major histocompatibility complex class 1 enhancer in adenovirus type 12-transformed cells. Mol. Cell. Biol. 19:2169-2179.
42. Li, R. C. X., P. Ping, J. Zhang, W. B. Wead, X. Cao, J. Gao, Y. Zheng, S. Huang, J. Han, and R. Bolli. 2000. PKCe modulates NF-κB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol, 279:H1679-H1689.
43. Liew, F. Y., Y. Li, and S. Millott. 1990. Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145:4306-4310.
44. Liu, L., A. Paul, C. J. MacKenzie, C. Bryant, A. Graham, and R. Plevin. 2001. Nuclear factor κB is involved in lipopolysaccharide-stimulated induction of interferon regulatory factor-1 and GAS/GAF DNA-binding in human umbilical vein endothelial cells. Br. J. Pharmacol. 134:1629-1638.
45. Lowenstein, C. J., E. W. Alley, P. Raval, A. D. Snowman, S. H. Snyder, S. W. Russell, and W. J. Murphy. 1993. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90:9730-9734.
46. MacMicking, J. D., R. J. North, R. LaCourse, J. S. Mudgett, S. K. Shah, and C. F. Nathan. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94: 5243-5248.
47. Means, T. K., R. P. Pavlovich, D. Roca, M. W. Vermeulen, and M. J. Fenton. 2000. Activation of TNF-α transcription utilizes distinct MAP kinase pathways in different macrophage populations. J. Leukoc. Biol. 67:885-893.
48. Meyer, C. F., X. Wang, C. Chang, D. Templeton, and T. H. Tan. 1996. Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating κB enhancer activation. J. Biol. Chem. 271:8971-8976.
49. Moreno, C., J. Taverne, A. Mehlert, C. A. W. Bate, R. J. Brealey, A. Meager, G. A. W. Rook, and J. H. L. Playfair. 1989. Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin. Exp. Immunol. 76:240-245.
50. Murphy, W. J., M. Muroi, X. Zhang, T. Suzuki, and S. W. Russell. 1996. Both a basal and an enhancer 1B element is required for full induction of the mouse inducible nitric oxide synthase gene. J. Endotoxin Res. 3:381-393.
51. Nicholson, S., M. da Gloria Bonecini-Almeida, J. R. Lapa e Silva, C. Nathan, Q.-W. Xie, R. Mumford, J. R. Widner, J. Calaycay, J. Geng, N. Boechat, C. Linhares, W. Rom, and J. L. Ho. 1996. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 183:2293-2302.
52. Nozaki, Y., Y. Hasegawa, S. Ichiyama, I. Nakashima, and K. Shimokata. 1997. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect. Immun. 65:3644-3647.
53. Park, J.-H., and L. Levitt. 1993. Overexpression of mitogen-activated protein kinase (ERK1) enhances T-cell cytokine gene expression: role of AP1, NFAT, and NF-κB. Blood 82:2470-2477.
54. Pine, R. 2002. IRF and tuberculosis. J. Interferon Cytokine Res. 22:15-25.
55. Platten, M., W. Wick, J. Wischhusen, and M. Weller. 2001. N-[3,4-Dimethoxycinnamoy1]-anthronilic acid (tranilast) suppresses microglial inducible nitric oxide synthase (iNOS) expression and activity induced by interferongamma (IFN-γ). Br. J. Pharmacol. 134:1279-1284.
56. Read, M. A., J. E. Brownell, T. B. Gladysheva, M. Hottelet, L. A. Parent, M. B. Coggins, J. W. Pierce, V. N. Podust, R.-S. Luo, V. Chau, and V. J. Palombella. 2000. Nedd8 modification of Cul-1 activates SCF (β-TrCP)-dependent ubiquitination of IκBα. Mol. Cell. Biol. 20:2326-2333.
57. Rich, E. A., M. Torres, E. Sada, C. K. Finegan, B. D. Hamilton, and Z. Toossi. 1997. Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB. Tuber. Lung Dis. 78:247-255.
58. 3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophagelike cell line. Infect. Immun. 66:5314-5321.
59. Ropert, C., I. C. Almeida, M. Closel, L. R. Travassos, M. A. J. Ferguson, P. Cohen, and R. T. Gazzinelli. 2001. Requirement of mitogen-activated protein kinases and IκB phosphorylation for induction of proinflammatory cytokines synthesis by macrophages indicates functional similarity of receptors triggered by glycosylphosphatidylinositol anchors from parasitic protozoa and bacterial lipopolysaccharide. J. Immunol. 166:3423-3431.
60. Scanga, C. A., V. P. Mohan, K. Tanaka, D. Alland, J. L. Flynn, and J. Chan. 2001. The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice. Infect. Immun. 69:7711-7717.
61. Schlesinger, L. S., S. R. Hull, and T. M. Kaufman. 1994. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J. Immunol. 152:4070-4079.
62. Schouten, G. J., A. C. O. Vertegaal, S. T. Whiteside, A. Israel, M. Toebes, J. C. Dorsman, A. J. van der Eb, and A. Zantema. 1997. IκBα is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J. 16:3133-3144.
63. Stein, B., A. S. Baldwin, D. W. Ballard, W. C. Greene, P. Angel, and P. Herrlich. 1993. Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12:3879-3891.
64. Strohmeier, G. R., and M. J. Fenton. 1999. Roles of lipoarabinomannan in the pathogenesis of tuberculosis. Microbes Infect. 1:709-717.
65. Toossi, Z., B. D. Hamilton, M. H. Phillips, L. E. Averill, J. J. Ellner, and A. Salvekar. 1997. Regulation of nuclear factor-κB and its inhibitor IκB-α/ MAD-3 in monocytes by Mycobacterium tuberculosis and during human tuberculosis. J. Immunol. 159:4109-4116.
66. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
67. Wada, H., E. T. H. Yeh, and T. Kamitani. 2000. A dominant-negative UBC12 mutant sequesters NEDD8 and inhibits NEDD8 conjugation in vivo. J. Biol. Chem. 275:17008-17015.
68. Wang, C.-H., C.-Y. Liu, H.-C. Lin, C.-T. Yu, K.-F. Chung, and H.-P. Kuo. 1998. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur. Respir. J. 11:809-815.
69. Xie, Q., R. Whisnant, and C. Nathan. 1993. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide. J. Exp. Med. 177:1779-1784.
70. Xie, Q.-W., H. J. Cho, J. Calaycay, R. A. Mumford, K. M. Swiderek, T. D. Lee, A. Ding, T. Troso, and C. Nathan. 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225-228.
71. Yamada, H., S. Mizuno, M. Reza-Gholizadeh, and I. Sugawara. 2001. Relative importance of NF-κB p50 in mycobacterial infection. Infect. Immun. 69:7100-7105.
72. Yang, X., Y. Chen, and D. Gabuzda. 1999. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-κB. J. Biol. Chem. 274:27981-27988.
73. Yeh, E. T. H., L. Gong, and T. Kamitani. 2000. Ubiquitin-like proteins: new wines in new bottles. Gene 248:1-14.
74. Zhang, Y., M. Broser, and W. N. Rom. 1994. Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-κB. Proc. Natl. Acad. Sci. USA 91:2225-2229.
75. Zhang, Y., M. Doerfler, T. C. Lee, B. Guillemin, and W. N. Rom. 1993. Mechanisms of stimulation of interleukin-1β and tumor necrosis factor-α by Mycobacterium tuberculosis components. J. Clin. Investig. 91:2076-2083.
76. Zhong, H., R. E. Voll, and S. Ghosh. 1998. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1:661-671.